Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'TRIPLE THERAPY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 731 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. De Francesco, V; Zullo, A; Hassan, C; Faleo, D; Ierardi, E; Panella, C; Morini, S
      Two new treatment regimens for Helicobacter pylori eradication: a randomised study

      DIGESTIVE AND LIVER DISEASE
    2. Neville, PM; Barrowclough, S; Crocombe, W; Axon, ATR; Wrangstadh, M; Moayyedi, P
      Randomised study of the efficacy of Omeprazole and Clarithromycin with either Amoxycillin or Metronidazole in the eradication of Helicobacter pylori in screened primary care patients

      DIGESTIVE AND LIVER DISEASE
    3. Easterbrook, PJ; Newson, R; Ives, N; Pereira, S; Moyle, G; Gazzard, BG
      Comparison of virologic, immunologic, and clinical response to five different initial protease inhibitor-containing and nevirapine-containing regimens

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    4. Ungsedhapand, C; Kroon, EDMB; Suwanagool, S; Ruxrungtham, K; Yimsuan, N; Sonjai, A; Ubolyam, S; Buranapraditkun, S; Tiengrim, S; Pakker, N; Kunanusont, C; Lange, JMA; Cooper, DA; Phanuphak, P
      A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patients

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    5. Marimoutou, C; Chene, G; Mercie, P; Neau, D; Farbos, S; Morlat, P; Ceccaldi, J; Dabis, F
      Prognostic factors of combined viral load and CD4(+) cell count responses under triple antiretroviral therapy, aquitaine cohort, 1996-1998

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    6. Labenz, J
      Current role of acid suppressants in Helicobacter pylori eradication therapy

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    7. Metzger, J; Styger, S; Sieber, C; von Fliie, M; Vogelbach, P; Harder, F
      Prevalence of Helicobacter pylori infection in peptic ulcer perforations

      SWISS MEDICAL WEEKLY
    8. Grahovac, B; Bingulac-Popovic, J; Vucelic, B; Hrstic, I; Ostojic, R; Drazic, V; Balija, M; Grgicevic, D
      Dynamics of serum hepatitis C virus load and quasispecies complexity during antiviral therapy in patients with chronic hepatitis C

      JOURNAL OF CLINICAL VIROLOGY
    9. Williamson, JS
      Helicobacter pylori: Current chemotherapy and new targets for drug design

      CURRENT PHARMACEUTICAL DESIGN
    10. Moayyedi, P; Murphy, B
      Helicobacter pylori: a clinical update

      JOURNAL OF APPLIED MICROBIOLOGY
    11. de Boer, WA
      A novel therapeutic approach for Helicobacter pylori infection: the bismuth-based triple therapy monocapsule

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    12. Gomollon, F; Sicilia, B
      Helicobacter pylori: strategies for treatment

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    13. Bujanda, L; Herrerias, JM; Ripolles, V; Pena, D; Chaves-da-Cruz, A; Teixeira, C; Company, T; Fueyo, A
      Efficacy and tolerability of three regimens for Helicobacter pylori eradication - A multicentre, double-blind, randomised clinical trial

      CLINICAL DRUG INVESTIGATION
    14. Mones, J; Rodrigo, L; Sancho, F; Martin, L; Boixeda, D; Artes, MT; Garcia-Cases, C
      Helicobacter pylori eradication versus one-year maintenance therapy: effect on relapse and gastritis outcome

      REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
    15. Baffone, W; Pianetti, A; Citterio, B; Lombardelli, G; Vittoria, E; Bruscolini, F
      Studies on the development and stability of resistance of Helicobacter pylori to metronidazole and clarithromycin

      JOURNAL OF CHEMOTHERAPY
    16. Asaka, M; Sugiyama, T; Kato, M; Satoh, K; Kuwayama, H; Fukuda, Y; Fujioka, T; Takemoto, T; Kimura, K; Shimoyama, T; Shimizu, K; Kobayashi, S
      A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients

      HELICOBACTER
    17. Meyer, JM; Silliman, NP; Dixon, CA; Siepman, NY; Sugg, JE; Hopkins, RJ
      Helicobacter pylori and early duodenal ulcer status post-treatment: a review

      HELICOBACTER
    18. Phillips, RH; Whitehead, MW; Doig, LA; Sieniawska, CE; Delves, HT; Thompson, RPH; Powell, JJ
      Is eradication of Helicobacter pylori with colloidal bismuth subcitrate quadruple therapy safe?

      HELICOBACTER
    19. Gisbert, JP; Marcos, S; Gisbert, JL; Pajares, JM
      High efficacy of ranitidine bismuth citrate, amoxicillin, clarithromycin and metronidazole twice daily for only five days in Helicobacter pylori eradication

      HELICOBACTER

    20. ASHP therapeutic position statement on the identification and treatment ofHelicobacter pylori-associated peptic ulcer disease in adults

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    21. Chahine, C; Moukhachen, O; Chedid, M; Araj, GF; Sharara, AI
      Ultrashort regimen of lansoprazole-amoxicillin-azithromycin for eradicating Helicobacter pylori

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    22. Poole, P
      Pantoprazole

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    23. Goodman, KJ; Cockburn, M
      The role of epidemiology in understanding the health effects of Helicobacter pylori

      EPIDEMIOLOGY
    24. Harris, A
      Treatment of Helicobacter pylori

      WORLD JOURNAL OF GASTROENTEROLOGY
    25. Arici, C; Ripamonti, D; Ravasio, V; Maggiolo, F; Rizzi, M; Finazzi, MG; Suter, F
      Long-term clinical benefit after highly active antiretroviral therapy in advanced HIV-1 infection, even in patients without immune reconstitution

      INTERNATIONAL JOURNAL OF STD & AIDS
    26. Manfredi, R; Chiodo, F
      Switch of protease inhibitor-containing HAART in routine clinical practice: a four-year prospective observational study

      INTERNATIONAL JOURNAL OF STD & AIDS
    27. van Doorn, OJ; Bosman, DK; van't Hoff, BW; Taminiau, JA; ten Kate, FJ; van der Ende, A
      Helicobacter pylori Stool Antigen Test: a reliable non-invasive test for the diagnosis of Helicobacter pylori infection in children

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    28. Kaviani, MJ; Malekzadeh, R; Vahedi, H; Sotoudeh, M; Kamalian, N; Amini, M; Massarrat, S
      Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine for 1 or2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled trial

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    29. Hsu, CC; Chen, JJ; Hu, TH; Lu, SN; Changchien, CS
      Famotidine versus omeprazole, in combination with amoxycillin and tinidazole, for eradication of Helicobacter pylori infection

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    30. Marchi, S; Costa, F; Bellini, M; Belcari, C; Mumolo, MG; Tornar, A; Spisni, R; Torelli, E; Maltinti, G
      Ranitidine bismuth citrate-based triple therapy for seven days, with or without further anti-secretory therapy, is highly effective in patients with duodenal ulcer and Helicobacter pylori infection

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    31. Demir, K; Okten, A; Kaymakoglu, S; Dincer, D; Besisik, F; Cevikbas, U; Ozdil, S; Bostas, G; Mungan, Z; Cakologlu, Y
      Tuberculous peritonitis - reports of 26 cases, detailing diagnostic and therapeutic problems

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    32. de Boer, WA; Tytgat, GNJ
      Should anti-Helicobacter therapy be different in patients with dyspepsia compared with patients with peptic ulcer diathesis?

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    33. Gisbert, JP; Marcos, S; Gisbert, JL; Pajares, JM
      Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    34. van der Wouden, EJ; Thijs, JC; van Zwet, AA; Kleibeuker, JH
      Six-year follow-up after successful triple therapy for Helicobacter pyloriinfection in patients with peptic ulcer disease

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    35. Buzas, GM; Illyes, G; Szekely, E; Szeles, I
      Six regimens for the eradication of Helicobacter pylori (Hp) in duodenal ulcer patients: three consecutive trials (1995-1999)

      JOURNAL OF PHYSIOLOGY-PARIS
    36. Yang, YJ; Yang, JC; Jeng, YM; Chang, MH; Ni, YH
      Prevalence and rapid identification of clarithromycin-resistant Helicobacter pylori isolates in children

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    37. Lahaie, R; Farley, A; Dallaire, C; Archambault, A; Fallone, CA; Ponich, T; Hunt, R; Oravec, M; Whitsitt, P; Van Zanten, SV; Marcon, N; Bailey, R; Dumont, A; Nguyen, B; Desrochers, S; Spenard, J
      Bismuth-based quadruple therapy with bismuth subcitrate, metronidazole, tetracycline and omeprazole in the eradication of Helicobacter pylori

      CANADIAN JOURNAL OF GASTROENTEROLOGY
    38. Chiba, N; Hunt, RH; Thomson, ABR
      Ranitidine bismuth citrate

      CANADIAN JOURNAL OF GASTROENTEROLOGY
    39. Chaun, H
      Update on the role of H pylori infection in gastrointestinal disorders

      CANADIAN JOURNAL OF GASTROENTEROLOGY
    40. Sotudehmanesh, R; Malekzadeh, R; Fazel, A; Massarrat, S; Ziad-Alizadeh, B; Eshraghian, MR
      A randomized controlled comparison of three quadruple therapy regimens in a population with low Helicobacter pylori eradication rates

      JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    41. Bigard, MA
      Eradication of Helicobacter pylori - Therapeutic options and complementaryexplorations

      PRESSE MEDICALE
    42. Monforte, AD; Adorni, F; Meroni, L; Bini, T; Testa, L; Chiesa, E; Melzi, S; Rusconi, S; Sollima, S; Galli, M; Moroni, M
      Predictive role of the three-month CD4 cell count in the long-term clinical outcome of the first HAART regimen

      BIOMEDICINE & PHARMACOTHERAPY
    43. Bani-Hani, KE; Hammouri, SM
      Prevalence of Helicobacter pylori in Northern Jordan - Endoscopy based study

      SAUDI MEDICAL JOURNAL
    44. Tankovic, J; Lamarque, D; Lascols, C; Soussy, CJ; Delchier, JC
      Clarithromycin resistance of Helicobacter pylori has a major impact on theefficacy of the omeprazole-amoxicillin-clarithromycin therapy

      PATHOLOGIE BIOLOGIE
    45. Rosandic, M
      Antibiotic-resistance patterns of Helicobacter pylori in Croatia: Cohort study

      CROATIAN MEDICAL JOURNAL
    46. Endo, H; Yoshida, H; Ohmi, N; Higuchi, S
      Effects of lansoprazole, clarithromycin and pH gradient on uptake of [C-14]amoxycillin into rat gastric tissue

      Journal of antimicrobial chemotherapy
    47. Shcherbakov, PL; Filin, VA; Volkov, IA; Tatarinov, PA; Belousov, YB
      A randomized comparison of triple therapy Helicobacter pylori eradication regimens in children with peptic ulcers

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    48. Tolia, V
      Other experience with H-pylori therapy

      JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
    49. Wang, YL; Sheu, BS; Huang, JJ; Yang, HB
      Noninvasive stool antigen assay can effectively screen Helicobacter pyloriinfection and assess success of eradication therapy in hemodialysis patients

      AMERICAN JOURNAL OF KIDNEY DISEASES
    50. Lepri, AC; Phillips, AN; Monforte, AD; Castelli, F; Antinori, A; de Luca, A; Pezzotti, P; Alberici, F; Cargnel, A; Grima, P; Piscopo, R; Prestileo, T; Scalise, G; Vigevani, M; Moroni, M
      When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study

      AIDS
    51. Nieuwkerk, PT; Gisolf, EH; Reijers, MHE; Lange, JMA; Danner, SA; Sprangers, MAG
      Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection

      AIDS
    52. Fennerty, MB; Magaret, N; Dalros, L; Faigel, D; Lieberman, D; Shaw, M
      Outcomes of Helicobacter pylori treatment in community practice and impactof therapeutic effectiveness information on physician behaviour

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    53. Kamberoglou, D; Polymeros, D; Sanidas, I; Doulgeroglou, V; Savva, S; Patra, E; Tzias, V
      Comparison of 1-week vs. 2-or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    54. Calvet, X; Garcia, N; Gene, E; Campo, R; Brullet, E; Sanfeliu, I
      Modified seven-day, quadruple therapy as a first line Helicobacter pylori treatment

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    55. Wong, BCY; Wang, WH; Wong, WM; Lau, GKK; Fung, FMY; Kung, NNS; Chu, KM; Lai, KC; Hu, WHC; Hu, FL; Liu, XG; Chan, CK; Yuen, MF; Hui, WM; Lam, SK
      Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled study

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    56. Tankovic, J; Lamarque, D; Lascols, C; Soussy, CJ; Delchier, JC
      Impact of Helicobacter pylori resistance to clarithromycin on the efficacyof the omeprazole-amoxcillin-clarithromycin therapy

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    57. Wong, BCY; Wang, WH; Berg, DE; Fung, FMY; Wong, KW; Wong, WM; Lai, KC; Cho, CH; Hui, WM; Lam, SK
      High prevalence of mixed infections by Helicobacter pylori in Hong Kong: metronidazole sensitivity and overall genotype

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    58. Fakheri, H; Malekzadeh, R; Merat, S; Khatibian, M; Fazel, A; Alizadeh, BZ; Massarrat, S
      Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    59. Guslandi, M
      Review article: alternative antibacterial agents for Helicobacter pylori eradication

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    60. Louw, JA; Marks, IN
      The medical treatment of peptic ulcer disease

      CURRENT OPINION IN GASTROENTEROLOGY
    61. Hoffman, JS; Cave, DR
      Treatment of Helicobacter pylori

      CURRENT OPINION IN GASTROENTEROLOGY
    62. Gisbert, JP; Pajares, JM
      Helicobacter pylori therapy: First-line options and rescue regimen

      DIGESTIVE DISEASES
    63. Fanti, L; Ieri, R; Mezzi, G; Testoni, PA; Passaretti, S; Guslandi, M
      Long-term follow-up and serologic assessment after triple therapy with omeprazole or lansoprazole of Helicobacter-associated duodenal ulcer

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    64. Gisbert, JP; Hermida, C; Pajares, JM
      Are twelve days of omeprazole, amoxicillin and clarithromycin better than six days for treating H-pylori infection in peptic ulcer and in non-ulcer dyspepsia?

      HEPATO-GASTROENTEROLOGY
    65. Hsieh, YH; Lin, HJ; Tseng, GY; Perng, CL; Chang, FY; Lee, SD
      A 3-day anti-Helicobacter pylori therapy is a good alternative for bleeding peptic ulcer patients with Helicobacter pylori infection

      HEPATO-GASTROENTEROLOGY
    66. Miwa, H; Misawa, H; Yamada, T; Nagahara, A; Ohtaka, K; Sato, N
      Clarithromycin resistance, but not CYP2C-19 polymorphism, has a major impact on treatment success in 7-day treatment regimen for cure of H-pylori infection - A multiple logistic regression analysis

      DIGESTIVE DISEASES AND SCIENCES
    67. Fontana, G; Licciardi, M; Mansueto, S; Schillaci, D; Giammona, G
      Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: Influence of PEG coating on the particle size, drug release rate and phagocytic uptake

      BIOMATERIALS
    68. Phillips, AN; Staszewski, S; Weber, R; Kirk, O; Francioli, P; Miller, V; Vernazza, P; Lundgren, JD; Ledergerber, B
      HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    69. Havlir, DV; Bassett, R; Levitan, D; Gilbert, P; Tebas, P; Collier, AC; Hirsch, MS; Ignacio, C; Condra, J; Gunthard, HF; Richman, DD; Wong, JK
      Prevalence and predictive value of intermittent viremia with combination HIV therapy

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    70. Kalach, N; Benhamou, PH; Dupont, C; Raymond, J; Bergeret, M; Gottrand, F; Husson, MO
      Helicobacter pylori in children: Acquisition of antimicrobial resistance after an initial course of treatment

      JOURNAL OF CLINICAL MICROBIOLOGY
    71. Meurer, LN
      Treatment of peptic ulcer disease and nonulcer dyspepsia

      JOURNAL OF FAMILY PRACTICE
    72. Corsten, L; Raja, A; Guppy, K; Roitberg, B; Misra, M; Alp, S; Charbel, F; Debrun, G; Ausman, J
      Contemporary management of subarachnoid hemorrhage and vasospasm: The UIC experience

      SURGICAL NEUROLOGY
    73. Kanamaru, T; Nakano, Y; Toyoda, Y; Miyagawa, KI; Tada, M; Kaisho, T; Nakao, M
      In vitro and in vivo antibacterial activities of TAK-083, an agent for treatment of Helicobacter pylori infection

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    74. Endo, H; Yoshida, H; Ohmi, N; Higuchi, S
      Effects of lansoprazole and amoxicillin on uptake of [C-14]clarithromycin into gastric tissue in rats

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    75. van Praag, RME; Repping, S; de Vries, JWA; Lange, JMA; Hoetelmans, RMW; Prins, JM
      Pharmacokinetic profiles of nevirapine and indinavir in various fractions of seminal plasma

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    76. Luth, S; Teyssen, S; Kolbel, CB; Singer, MV
      4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease- A pilot study

      ZEITSCHRIFT FUR GASTROENTEROLOGIE
    77. Berg, T; Naumann, U; Wiedenmann, B; Hopf, U
      Pilot study of interferon-alpha high-dose induction therapy in combinationwith ribavirin plus amantadine for nonresponder patients with chronic hepatitis C

      ZEITSCHRIFT FUR GASTROENTEROLOGIE
    78. Hojo, M; Miwa, H; Nagahara, A; Sato, N
      Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    79. Ogura, K; Yoshida, H; Maeda, S; Yamaji, Y; Kawabe, T; Okamoto, M; Shiratori, Y; Omata, M
      Clarithromycin-based triple therapy for non-resistant Helicobacter pylori infection - How long should it be given?

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    80. Bateson, MC
      Quadruple therapy for symptomatic spontaneous duodenal ulcer disease

      POSTGRADUATE MEDICAL JOURNAL
    81. Ieiri, I; Kishimoto, Y; Okochi, H; Momiyama, K; Morita, T; Kitano, M; Morisawa, T; Fukushima, Y; Nakagawa, K; Hasegawa, J; Otsubo, K; Ishizaki, T
      Comparison of the kinetic disposition of and serum gastrin change by lansoprazole versus rabeprazole during an 8-day dosing scheme in relation to CYP2C19 polymorphism

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    82. Gisbert, JP; Pajares, JM
      Helicobacter pylori resistance to metronidazole and to clarithromycin in Spain. A systematic review

      MEDICINA CLINICA
    83. Antelo, P; Almuzara, M; Avagnina, A; Topor, J; Barberis, C; Barcia, T; Araujo, G; Vay, C; Famiglietti, A
      Diagnosis and treatment of Helicobacter pylori infection. Relationship with gastroduodenal ulcer and antimicrobial resistance.

      MEDICINA-BUENOS AIRES
    84. Vonmoos, F; Messerli, J; Moser, HR; Prunte, C; Flammer, J; Haefliger, IO
      Immunosuppressive therapy in serpiginous choroiditis - case report and brief review of the literature

      KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE
    85. Gottrand, F; Kalach, N; Spyckerelle, C; Guimber, D; Mougenot, JF; Tounian, P; Lenaerts, C; Roquelaure, B; Lachaux, A; Morali, A; Dupont, C; Maurage, C; Husson, MO; Barthelemy, P
      Omeprazole combined with amoxicillin and clarithromycin in the eradicationof Helicobacter pylori in children with gastritis: A prospective randomized double-blind trial

      JOURNAL OF PEDIATRICS
    86. Chan, KL; Zhou, H; Ng, DKK; Tam, PKH
      A prospective study of a one-week nonbismuth quadruple therapy for childhood Helicobacter pylori infection

      JOURNAL OF PEDIATRIC SURGERY
    87. Jenks, PJ
      Helicobacter pylori: towards new therapeutic targets

      JOURNAL OF MEDICAL MICROBIOLOGY
    88. O'Connor, HJ; Stewart, C; Walsh, R; McGee, C; Flynn, B
      Six-year follow-up after Helicobacter pylori eradication in peptic ulcer disease

      IRISH JOURNAL OF MEDICAL SCIENCE
    89. Leung, WK; Graham, DY
      Ulcer and gastritis

      ENDOSCOPY
    90. Matheson, AJ; Jarvis, B
      Lansoprazole An update of its place in the management of acid-related disorders

      DRUGS
    91. Liem, LK; Choong, LHL; Woo, KT
      Action of dipyridamole and warfarin on growth of human endothelial cells cultured in serum-free media

      CLINICAL BIOCHEMISTRY
    92. Jorgensen, MA; Trend, MA; Hazell, SL; Mendz, GL
      Potential involvement of several nitroreductases in metronidazole resistance in Helicobacter pylori

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    93. Nguyen, HN
      Eridication treatment of Helicobacter pylori in antibiotic resistance

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    94. de Boer, WA; Borody, TJ
      Treatment failures and secondary resistance to antibiotics. A growing concern in Helicobacter pylori therapy

      DIGESTIVE AND LIVER DISEASE
    95. De Francesco, V; Zullo, A; Rinaldi, V; Hassan, C; Ballanti, P; Winn, S; Diana, F; Morini, S; Attili, AF
      Relationship between antral lymphocyte density and basel gastrin levels inpatients with Helicobacter pylori infection

      DIGESTIVE AND LIVER DISEASE
    96. Maconi, G; Russo, A; Imbesi, V; Cucino, C; Porro, GB
      Prolonging proton pump inhibitor-based anti-Helicobacter pylori treatment from one to two weeks in duodenal ulcer: is it worthwhile?

      DIGESTIVE AND LIVER DISEASE
    97. Sherwood, P; Spiller, R
      Could the duration of anti-Helicobacter pylori treatment be shorter?

      DIGESTIVE AND LIVER DISEASE
    98. Moayyedi, P
      Finding the optimum treatment for Helicobacter pylori

      DIGESTIVE AND LIVER DISEASE
    99. Perri, F
      Diagnosis of Helicobacter pylori infection: which is the best test? The urea breath test

      DIGESTIVE AND LIVER DISEASE
    100. Bazzoli, F; Olivieri, L; De Luca, L; Pozzato, P; Lehours, P; Megrand, F
      Therapy and drug resistance in Helicobacter pylori infection

      DIGESTIVE AND LIVER DISEASE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/06/20 alle ore 12:36:57